← Leaderboards
Timothy T Wheeler
University Of Florida
$1,885,991
Attributed
$1,885,991
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $317.3K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$1,885,991 · 3
By mechanism
R01$1,594,703 · 1
M01$291,288 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Margarete C Ribeiro-Dasilva$1,444,940
- Kesavalu Naidu Lakshmyya$4,955,367
- Irene R Hurst$381,008
- Lexie Shannon Holliday$2,010,472
- Edward K Chan$5,663,390
Others in their field
Top investigators on “Health Care Cost /Financing”
- Bruce J Hillman · American College Of Radiology$58,288,467
- Robert W Hobson · Univ Of Med/Dent Of Nj-Nj Medical School$20,632,366
- John L Bryant · University Of Pittsburgh At Pittsburgh$15,641,104
- George E Woody · University Of Pennsylvania$11,441,237
- Richard L Schilsky · University Of Chicago$8,012,536
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$7,955,657
Research focus
Health Care Cost /FinancingOrthodonticsPatient Oriented ResearchCost EffectivenessClinical TrialsHealth BehaviorLongitudinal Human StudyMalocclusionHuman SubjectSelf ConceptMiddle Childhood (6-11)Oral HealthTherapy ComplianceHuman Therapy EvaluationCephalometryAge DifferenceAdolescence (12-20)OrganOrthodonticOrthodontic AppliancesPeriodontal LigamentRecombinantsRelapseRelaxin
Grant awards (7)
EFFICACY OF RECOMBINANT HUMAN RELAXIN (RHRIX) ADMINISTERED BY GINGIVAL INJECTION$19,296
M01 · FY2007 · RR · contact PI
EFFICACY OF RECOMBINANT HUMAN RELAXIN (RHRIX) ADMINISTERED BY GINGIVAL INJECTION$271,992
M01 · FY2006 · RR · contact PI
TIMING OF TREATMENT FOR CLASS II MALOCCLUSIONS$317,311
R01 · FY2005 · DE
TIMING OF TREATMENT FOR CLASS II MALOCCLUSIONS$317,091
R01 · FY2004 · DE
TIMING OF TREATMENT FOR CLASS II MALOCCLUSIONS$316,434
R01 · FY2003 · DE
TIMING OF TREATMENT FOR CLASS II MALOCCLUSIONS$316,434
R01 · FY2002 · DE
TIMING OF TREATMENT FOR CLASS II MALOCCLUSIONS$327,433
R01 · FY2001 · DE